DNA · Ginkgo Bioworks Holdings, Inc.

$6.79 -0.45 (-6.22%) At close · Aug 14

Market Cap

$457.24M

67.34M

Press releases and events scraped from the company's investor relations website. Past events open our own call or event page when we host one; otherwise listings link to the original source.

Recent news

Date	Headline
2026-08-05	Ginkgo Bioworks Reports Second Quarter 2026 Results, Wins Government Contracts to Build Autonomous Labs at MIT, Caltech, Northwestern, and University of Maryland
2026-08-05	Ginkgo Bioworks Expands Autonomous Lab Network to Caltech, MIT, Maryland and Northwestern
2026-08-03	Ginkgo Bioworks and Acies Bio Partner to Expand Global Access to High-Performance Aspergillus niger Strains for Protein Production
2026-07-30	Ginkgo Bioworks Announces Date of Second Quarter 2026 Results Presentation
2026-05-26	Ginkgo Datapoints, Tangible Scientific, and Inductive Bio Launch ADME-One™: a High-Throughput ADME Platform That Brings Pharmacokinetic Projection Earlier in Drug Discovery
2026-05-07	Ginkgo Bioworks Reports First Quarter 2026 Financial Results, Completes Divestiture of Biosecurity and Continues to Scale Autonomous Lab
2026-04-30	Ginkgo Bioworks Announces Date of First Quarter 2026 Results Presentation
2026-03-02	Ginkgo Bioworks Launches Ginkgo Cloud Lab, Powered by Autonomous Lab Infrastructure
2026-02-26	Ginkgo Bioworks Reports Fourth Quarter and Full Year 2025 Financial Results, Announces Focus on Autonomous Labs Offerings and Divestiture of its Non-Core Biosecurity Business
2026-02-19	Ginkgo Bioworks Announces Date of Fourth Quarter and Full Year 2025 Results Presentation
2026-02-18	Ginkgo Bioworks and Invaio Sciences Enter Collaboration to Develop Manufacturing Technology for Peptide-based Agricultural Products
2026-02-05	Ginkgo Bioworks' Autonomous Laboratory Driven by OpenAI's GPT-5 Achieves 40% Improvement Over State-of-the-Art Scientific Benchmark
2026-01-13	Ginkgo Bioworks Announces Participation in the 44th Annual J.P. Morgan Healthcare Conference
2025-12-22	Ginkgo Bioworks Partners with Carnegie-Mellon University to Develop Innovative New Cancer Screening Approach

Past events

Date	Event	Type
2026-08-05	Earnings conference call (announced in 8-K)	Earnings call
2026-05-07	Earnings conference call (announced in 8-K)	Earnings call
2026-02-26	Ginkgo Bioworks Announces Date of Fourth Quarter and Full Year 2025 Results Presentation	Earnings call
2026-01-15	Ginkgo Bioworks Announces Participation in the 44th Annual J.P. Morgan Healthcare Conference	Conference
2025-11-06	Ginkgo Bioworks Q3 2025 Results	Event
2025-08-07	Ginkgo Bioworks Q2 2025 Results	Event
2025-05-06	Ginkgo Bioworks Q1 2025 Results	Event
2025-02-25	Ginkgo Bioworks Q4 and Full Year 2024 Update & Business Review	Event
2025-01-16	JP Morgan Annual Healthcare Conference	Conference
2024-11-12	Ginkgo Bioworks Q3 2024 Results	Event
2024-09-06	Morgan Stanley 22nd Annual Global Healthcare Conference	Conference
2024-08-08	Ginkgo Bioworks Q2 2024 Results	Event
2024-05-30	Leerink Partners Healthcare Crossroads Conference	Conference
2024-05-22	TD Cowen 2nd Annual Sustainability Week	Event
2024-05-09	Ginkgo Bioworks Q1 2024 Results	Event
2024-04-11	Ginkgo Ferment 2024	Event
2024-03-04	TD Cowen 44th Annual Health Care Conference	Conference
2024-02-29	Q4 & YE 2023 Results	Event
2024-01-10	JP Morgan Annual Healthcare Conference	Conference
2023-11-08	Ginkgo Bioworks Q3 2023 Results	Event
2023-10-03	October 2023 Investor Day	Presentation
2023-09-13	Morgan Stanley 21st Annual Global Healthcare Conference	Conference
2023-08-15	UBS MedTech, Tools and Genomics Summit	Event
2023-08-09	Ginkgo Bioworks Q2 2023 Results	Event
2023-06-12	Goldman Sachs Global Healthcare Conference	Conference

Source: https://investors.ginkgobioworks.com/

Key facts CIK 1830214 CUSIP 37611X209 13F (30d) 184 filings 174 filers Visit website Investor relations